DiviDrip · RLMD

RLMD — Relmada Therapeutics, Inc.

RLMD is Relmada Therapeutics, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $4.43. Market cap: $473M. Capital Quality Rank: 47/100 — Stagnant mediocrity.

Stock snapshot

Price$4.43
Market cap$473M
SectorHealthcare
ExchangeNCM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)47 / 100 · Stagnant mediocrity
ROIC (TTM)-30.7%
Shareholder buyback yield-23.60%
Altman Z-score zoneSafe

About RLMD

Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.

Listed2014Employees17HQCoral Gables, FLSectorHealthcareWebsiterelmada.com

Related non-dividend companies

Other non-dividend stocks investors research alongside RLMD. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is RLMD's current stock price?

RLMD (Relmada Therapeutics, Inc.) is currently trading at $4.43.

Does RLMD pay a dividend?

RLMD (Relmada Therapeutics, Inc.) does not currently pay a regular dividend.

What is RLMD's Capital Quality Rank?

RLMD has a Capital Quality Rank of 47/100 — Stagnant mediocrity. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track RLMD in DiviDrip

Add RLMD to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-06. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow